Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Microvision Q1 Loss Widens - Quick Facts

Microvision Inc. (MVIS: Quote) reported that its first-quarter net loss was $9.8 million, or $0.58 per share, compared to a loss $9.0 million, or $0.70 per share for the same quarter a year ago.

Revenue was $1.7 million, compared to $1.1 million a year ago, primarily from the sale of current generation PicoP display engines and the SHOWWX family of pico projectors.

Analysts polled by Thomson Reuters expected the company to report a loss of $0.50 per share on revenues of $1.27 million for the quarter. Analysts' estimates typically exclude special items.

MicroVision said it plans to reduce its cash used in operations by approximately 50% during the second half of 2012 to align to its "Image by PicoP" ingredient brand model.

Click here to receive FREE breaking news email alerts for Microvision Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.